mRNA |
BRD-K27224038 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
0.009 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.009 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.009 |
mRNA |
foretinib |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.009 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.009 |
mRNA |
LRRK2-IN-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.009 |
mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.01 |
mRNA |
linifanib |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.01 |
mRNA |
NVP-ADW742 |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.01 |
mRNA |
BRD-K30019337 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.01 |